BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34728496)

  • 1. CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
    Bernard-Valnet R; Moisset X; Maubeuge N; Lefebvre M; Ouallet JC; Roumier M; Lebrun-Frenay C; Ciron J; Biotti D; Clavelou P; Godeau B; Du Pasquier RA; Martin-Blondel G
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
    Scarpazza C; Prosperini L; Mancinelli CR; De Rossi N; Lugaresi A; Capobianco M; Moiola L; Naldi P; Imberti L; Gerevini S; Capra R
    J Neurol Sci; 2017 Jul; 378():233-237. PubMed ID: 28566170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution inflammatory syndrome in natalizumab-associated PML.
    Tan IL; McArthur JC; Clifford DB; Major EO; Nath A
    Neurology; 2011 Sep; 77(11):1061-7. PubMed ID: 21832229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.
    Shahani L; Shah M; Tavakoli-Tabasi S
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26063110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
    N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
    Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.
    Tan K; Roda R; Ostrow L; McArthur J; Nath A
    Neurology; 2009 Apr; 72(17):1458-64. PubMed ID: 19129505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.
    Summers NA; Kelley CF; Armstrong W; Marconi VC; Nguyen ML
    AIDS Res Hum Retroviruses; 2019 Jun; 35(6):544-552. PubMed ID: 30834775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
    Giacomini PS; Rozenberg A; Metz I; Araujo D; Arbour N; Bar-Or A;
    N Engl J Med; 2014 Jan; 370(5):486-8. PubMed ID: 24476450
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.
    Metz I; Radue EW; Oterino A; Kümpfel T; Wiendl H; Schippling S; Kuhle J; Sahraian MA; Gray F; Jakl V; Häusler D; Brück W
    Acta Neuropathol; 2012 Feb; 123(2):235-45. PubMed ID: 22057786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy.
    Scarpazza C; Prosperini L; De Rossi N; Moiola L; Sormani MP; Gerevini S; Capra R;
    Ann Neurol; 2017 Nov; 82(5):697-705. PubMed ID: 29023856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review.
    Fournier A; Martin-Blondel G; Lechapt-Zalcman E; Dina J; Kazemi A; Verdon R; Mortier E; de La Blanchardière A
    Front Immunol; 2017; 8():577. PubMed ID: 28588577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
    Gheuens S; Smith DR; Wang X; Alsop DC; Lenkinski RE; Koralnik IJ
    Neurology; 2012 May; 78(18):1390-3. PubMed ID: 22517104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc.
    Stork L; Brück W; Bar-Or A; Metz I
    Acta Neuropathol; 2015 Mar; 129(3):467-8. PubMed ID: 25604548
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy.
    Scabini S; Trunfio M; Pirriatore V; Imperiale D; Audagnotto S; Bertucci R; Ghisetti V; Cinnirella G; Cistaro A; Perna M; Calcagno A; Di Perri G
    Infez Med; 2018 Jun; 26(2):160-163. PubMed ID: 29932090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS.
    Wattjes MP; Wijburg MT; van Eijk J; Frequin S; Uitdehaag BMJ; Barkhof F; Warnke C; Killestein J;
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):535-541. PubMed ID: 29142146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
    Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
    Front Immunol; 2019; 10():1188. PubMed ID: 31191548
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
    Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; de Vos M; Richert ND; Uitdehaag BM; Barkhof F; Killestein J;
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):879-84. PubMed ID: 26369555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.